Project Grant R34HL186416
- The National Heart, Lung, and Blood Institute awarded Emma Pendleton Bradley Hospital $175,175 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and implement a digital sleep intervention for preschoolers in foster care. The award funds development, pretesting, and evaluation of Nurturing Sleep, a trauma-informed digital public-health-level sleep intervention administered to foster caregivers of children ages 36–71 months. Aim 1 involves...
- The National Heart Lung and Blood Institute awarded New York University School of Medicine $795,421 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate sex-specific responses to obstructive sleep apnea therapies. The research examines how oxidative stress mediates cardiovascular harm from obstructive sleep apnea, with particular focus on sex differences in treatment response. The study tests N-acetylcysteine, an antioxidant precursor that...
- The National Heart, Lung, and Blood Institute awarded Yale University $839,771 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 1, 2026, to develop and refine a behavioral sleep intervention for low-income families in pediatric primary care settings. Yale will adapt and test Sleep Well, Bee Well (SWBW), an evidence-based intervention grounded in social cognitive theory, for implementation in primary care offices serving low-income populations. The R61 phase (Year...
- The National Heart, Lung, and Blood Institute awarded the University of North Carolina at Chapel Hill $166,248 on September 26, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct research triangulating causal effects of sleep, inflammation, and cardiometabolic disease. The research will identify oxylipin biomarkers associated with sleep problems—including insomnia, sleep apnea, and short sleep duration—and their relationship to cardiometabolic disease. The study...
- The National Heart, Lung, and Blood Institute awarded Brigham & Women's Hospital Inc. $353,776 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 20, 2025. The award funds investigation of place-based factors contributing to sleep health disparities in the United States. The research links nationwide public health surveillance data to neighborhood-level factors using geographic information science to test whether individual-level and place-based factors...
- The National Institute on Aging awarded Emory University $1,370,546 on February 15, 2026, under the Aging Research program (CFDA 93.866) to conduct a randomized controlled trial testing cognitive behavioral therapy for insomnia (CBT-I) delivered to dyads of persons living with dementia and their caregivers. The study, titled "Testing Cognitive Behavioral Therapy for Insomnia (CBT-I) on Dyadic Sleep in Dementia: A Randomized Control Trial," will enroll 120 dyads and compare the efficacy...
- The National Heart, Lung, and Blood Institute awarded the Icahn School of Medicine at Mount Sinai $193,467 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support career development and a pilot prospective randomized clinical trial examining sleep restriction therapy for co-morbid insomnia and sleep apnea (COMISA). The award funds Dr. Thomas M. Tolbert's transition to career independence as a physician-scientist studying the heterogeneous pathophysiology of...
- The National Heart Lung and Blood Institute (NHLBI) awarded the University of South Carolina $100,000 on September 1, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to conduct a randomized controlled trial evaluating a prevention-focused behavioral sleep intervention for parents of preschool-aged children. The study will enroll 198 parent-child dyads (children ages 2–4 years with insufficient sleep at baseline and no reported sleep disorder) and randomize them to receive either...
- The National Institute of Child Health and Human Development awarded Children's Research Institute $500,500 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.HDR) to conduct a prospective observational study integrating bedside sleep monitoring tools for preterm infants during the neonatal intensive care unit (NICU) stay. The research addresses sleep-cycle maturation in preterm infants born during the extrauterine third trimester. Sleep...
- The National Heart, Lung, and Blood Institute awarded Emory University $100,228 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct longitudinal research examining associations between sleep health, protective factors against psychosocial adversity, and stress-related biomarkers including allostatic load and epigenetic age acceleration. The project analyzes multidimensional sleep health—encompassing regularity, satisfaction, alertness, timing,...
The National Heart, Lung, and Blood Institute awarded the Research Foundation For Mental Hygiene, Inc., operating through its New York State Psychiatric Institute, $261,716 on July 22, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to adapt and pilot a doula-delivered cognitive behavioral therapy for insomnia (CBT-I) intervention for pregnant individuals experiencing prenatal sleep disturbances. The project addresses the gap between evidence-based CBT-I treatment efficacy for pregnancy-related insomnia and limited access due to workforce constraints—only 6 percent of clinical psychologists are trained in behavioral sleep medicine, and approximately 40 percent of adults drop out of CBT-I prematurely. The intervention model leverages doulas, non-clinical community-based perinatal support workers who have sustained contact with families, shared community backgrounds, and growing integration into health systems including via Medicaid. National surveys document strong interest among doulas in delivering mental health and sleep health interventions. The recipient will conduct the work through a human-centered design implementation-focused process beginning with a community sleep needs assessment to identify perinatal sleep-related strengths, assets, and needs in the target population. Performance occurs in New York, NY. The period of performance runs from the award date through June 30, 2029. This is a Project Grant, the assistance type used by NIH for discrete research initiatives of defined scope and duration.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $261.7k | 7/22/26 |